Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01145898 · ClinicalTrials.gov registry record

Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data

A clinical trial of Glaucoma, sponsored by Indiana University.

Completed
Registry status
56
Enrollment target
1
Study location

NCT01145898 is a study of Glaucoma that has completed, run by Indiana University. The registered enrollment target is 56 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01145898, a study of Glaucoma, has completed, sponsored by Indiana University.

COMPLETED
Registry status
56 participants
Enrollment target
1
Study location

Study Summary

To analyze Cosopt® in terms of its effects on ocular perfusion pressure and comprehensive ocular blood flow and in relation to visual field progression and optic nerve structural changes in an ongoing 3 year prospective study involving 120 patients with open angle glaucoma.

Conditions Studied

Interventions

  • DRUG (Cosopt®, prostaglandin)

Study Locations (1)

Indiana

  • Indiana University School of Medicine, Department of Ophthalmology - Indianapolis

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2010-06
Est. Completion 2012-10

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT01145898

The ClinicalTrials.gov registry entry for NCT01145898 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (94% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which (Cosopt®, prostaglandin) is the first listed.

NCT01145898 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT01145898 about?

NCT01145898 is a clinical study titled "Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data". To analyze Cosopt® in terms of its effects on ocular perfusion pressure and comprehensive ocular blood flow and in relation to visual field progression and optic nerve structural changes in an ongoing 3 year prospective study involving 120 patients with open angle glaucoma.

What is the current status of trial NCT01145898?

This trial is currently completed. The enrollment target is 56 participants. The study started on 2010-06. Estimated completion is 2012-10.

What conditions does trial NCT01145898 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT01145898?

The interventions under investigation include: (Cosopt®, prostaglandin) (DRUG).

Who is sponsoring clinical trial NCT01145898?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01145898 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.